Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 207 | 4 | 213 | +10 |
| Shares | 29.8M | 24.3K | 29.1M | −680.0K (−2.3%) |
| Value | $839.3M | $683.0K | $816.7M | −$21.9M (−2.6%) |
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (16)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Robeco Institutional Asset Management B.V. | 36,497 | $1.03M |
| Marshall Wace, LLP | 31,638 | $890.0K |
| Jackson Creek Investment Advisors LLC | 27,577 | $775.0K |
| SEI Investments Co | 25,632 | $720.0K |
| State Board of Administration of Florida Retirement System | 18,259 | $513.0K |
| Advisory Research Inc | 15,148 | $426.0K |
| APG Asset Management N.V. | 13,400 | $384.0K |
| Susquehanna International Group, LLP | 12,368 | $348.0K |
| Ensign Peak Advisors, Inc | 10,900 | $306.0K |
| SG3 Management, LLC | 8,878 | $249.5K |
| Hennion & Walsh Asset Management, Inc. | 7,286 | $205.0K |
| FinTrust Capital Advisors, LLC | 7,000 | $196.0K |
| Point72 Hong Kong Ltd | 2,683 | $75.0K |
| Macquarie Group Ltd | 0 | $13.0K |
| Meeder Asset Management Inc | 175 | $5.00K |
| Absolute Capital Management, LLC | 37 | $1.07K |
Not filed for Q4 2022 yet (4)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Bluestein R H & Co | 12,500 | $351.0K |
| Hightower 6M Holding, LLC | 10,307 | $290.0K |
| USA Financial Portformulas Corp | 1,181 | $33.0K |
| Wipfli Financial Advisors LLC, | 331 | $9.00K |